Page last updated: 2024-12-07

ribulose-1,5 diphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ribulose-1,5 diphosphate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-ribulose 1,5-bisphosphate : A ribulose phosphate that is D-ribulose attached to phosphate groups at positions 1 and 5. It is an intermediate in photosynthesis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123658
CHEBI ID16710
SCHEMBL ID26828
MeSH IDM0042340

Synonyms (37)

Synonym
ribulose-1,5-diphosphate
d-erythro-pentulose 1,5-bis(dihydrogen phosphate)
1,5-di-o-phosphono-d-ribulose
d-ribulose 1,5-bis(dihydrogen phosphate)
CHEBI:16710
1,5-di-o-phosphono-d-erythro-pent-2-ulose
24218-00-6
d-ribulose 1,5-bisphosphate
C01182
ribulose 1,5-bisphosphate
ribulose-1,5-bis-p
F43463CC-DA7F-48A6-B612-7A3C1BA197DC
[(2r,3r)-2,3-dihydroxy-4-oxo-5-phosphonooxypentyl] dihydrogen phosphate
erythro-2-pentulose, 1,5-bis(dihydrogen phosphate)
ribulose-1,5 diphosphate
2002-28-0
ribulose-1,5-bisphosphate
SCHEMBL26828
DTXSID30173837
[(2r,3r)-2,3-dihydroxy-4-keto-5-phosphonooxy-pentyl] dihydrogen phosphate
[(2r,3r)-2,3-bis(oxidanyl)-4-oxidanylidene-5-phosphonooxy-pentyl] dihydrogen phosphate
ribulose 1,5-diphosphate
J-008280
d-ribulose 1,5-bisphosphate sodium salt
unii-br374x7nah
d-erythro-pentulose, diphosphate
d-ribulose diphosphate
d-erythro-2-pentulose, bis(dihydrogen phosphate)
d-erythro-pentulose, bis(dihydrogen phosphate)
d-ribulose diphosphate [mi]
d-erythro-pentulose, 1,5-bis(dihydrogen phosphate)
d-erythro-2-pentulose, 1,5-bis(dihydrogen phosphate)
d-ribulose 1,5-diphosphate
BR374X7NAH ,
Q418860
14689-84-0 free acid
rudp

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Strikingly, G1P in combination with T6P inhibited SnRK1 synergistically."( Inhibition of SnRK1 by metabolites: tissue-dependent effects and cooperative inhibition by glucose 1-phosphate in combination with trehalose 6-phosphate.
Davis, BG; Fevereiro, PS; Martinez-Barajas, E; Nunes, C; Patel, MK; Paul, MJ; Powers, SJ; Primavesi, LF; Sagar, R, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ribulose phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Photosynthesis6324
Calvin-Benson Cycle1321
Carbon assimilation C4 pathway030
Photosynthetic carbon reduction014

Research

Studies (116)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (14.66)18.7374
1990's17 (14.66)18.2507
2000's24 (20.69)29.6817
2010's57 (49.14)24.3611
2020's1 (0.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.93 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index80.64 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other112 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]